Importantly, we, for the first time, revealed that the protein expressions of ALDH2, CCNE1 and SMAD3 were significant and independent prognostic markers for patients with UTUC, which may facilitate the clinical management of this cancer. This evidence concerns the gene ALDH2 and renal pelvis/ureter urothelial carcinoma.